Janus Henderson Group’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Janus Henderson Group’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,476,193	Closed	-$83.5M	–	2746
2022 Q1	$83.5M	Sell	4,476,193 -3,592,340	-45%	-$64.6M	0.04%	361
2021 Q4	$173M	Sell	8,068,533 -169,553	-2%	-$3.34M	0.07%	261
2021 Q3	$152M	Buy	8,238,086 +1,873,161	+29%	+$37.7M	0.07%	281
2021 Q2	$136M	Sell	6,364,925 -721,162	-10%	-$14.7M	0.06%	309
2021 Q1	$137M	Buy	+7,086,087	New	+$125M	0.06%	300

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Janus Henderson Group's OCDX Position: Q2 2022 in Review

Janus Henderson Group sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 4,476,193 shares — an estimated $83.5M sold.

Janus Henderson Group first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $173M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Janus Henderson Group reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Janus Henderson Group sold 4,476,193 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $83.5M.
Janus Henderson Group first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
Janus Henderson Group's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $173M in Q4 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Janus Henderson Group's 13F filing for Q2 2022, filed 15 Aug 2022.